Canada's Drug Agency says new Alzheimer's drug should not be publicly funded | Page 12 | Unpublished
Hello!
Source Feed: Ottawa Citizen
Author: Elizabeth Payne
Publication Date: February 28, 2026 - 04:00

Stay informed

Canada's Drug Agency says new Alzheimer's drug should not be publicly funded

February 28, 2026
A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher. Read More


Unpublished Newswire

 
CNRL says it's putting Jackpine mine expansion spending on hold until it gets more clarity around expected changes to federal carbon pricing and methane emissions rules.
March 5, 2026 - 15:58 | Globalnews Digital | Global News - Canada
The spike in sales was fuelled, in large part, by the company’s emphasis on value deals, A&W CEO Susan Senecal said in a statement.
March 5, 2026 - 15:56 | Uday Rana | Global News - Canada